Article
The Synergism Between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in…
medRxiv · 2020 · Gaidano, V.; Houshmand, M.; Vitale, N.; Carra, G.; Morotti, A.; Tenace, V.; Rapelli, S.; Sainas, S.; Pippione, A. C.; Giorgis, M.; Boschi, D.; Lolli, M. L.; Cignetti, A.; Saglio, G.; Circosta, P.
Key facts
| Title | The Synergism Between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia |
|---|---|
| First author | Gaidano, V.; Houshmand, M.; Vitale, N.; Carra, G.; Morotti, A.; Tenace, V.; Rapelli, S.; Sainas, S.; Pippione, A. C.; Giorgis, M.; Boschi, D.; Lolli, M. L.; Cignetti, A.; Saglio, G.; Circosta, P. |
| Journal | medRxiv |
| Published | Oct 13, 2020 |
| DOI | 10.1101/2020.10.10.334631 |
| Devices mentioned | K060774, K963139 |
| Product codes mentioned | CGN, DDD, DDG, JQP, MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1